Drugs Made in America Acquisition (DMAAU) Stock Price, News & Analysis

Company Overview

Drugs Made in America Acquisition Corp is a special purpose acquisition company incorporated in Delaware and traded on the NASDAQ under the ticker DMAAU. It was organized to raise capital through its initial public offering and to identify and complete a business combination with one or more U.S.-based pharmaceutical or biotechnology companies.

The company’s investment mandate is focused on target businesses engaged in the development, manufacture or commercialization of finished dosage pharmaceuticals, active pharmaceutical ingredients and related medical products for the American market. By concentrating on firms that contribute to domestic drug manufacturing and supply chain resilience, DMAAU aims to support improved patient access to essential therapies.

Until it consummates a qualifying transaction, Drugs Made in America Acquisition Corp holds its IPO proceeds in a trust account and evaluates potential partners that align with its strategic objectives. The management team combines experience in pharmaceutical operations, private equity and investment banking to source and execute a value-creating business combination.

Key Stats

• Today's Range: $10.57 to $10.58
• 50-Day Range: $10.50 to $10.99
• 52-Week Range: $10.00 to $10.60
• Volume: 86 shs
• Average Volume: 8,056 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

DMAAU Stock Analysis - Frequently Asked Questions

How have DMAAU shares performed this year?

Drugs Made in America Acquisition's stock was trading at $10.49 at the beginning of 2026. Since then, DMAAU shares have increased by 0.9% and is now trading at $10.58.

When did Drugs Made in America Acquisition IPO?

Drugs Made in America Acquisition (DMAAU) raised $200 million in an initial public offering on Tuesday, January 28th 2025. The company issued 20,000,000 shares at a price of $10.00 per share. Clear Street served as the underwriter for the IPO.

How do I buy shares of Drugs Made in America Acquisition?

Shares of DMAAU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Finance
• Industry: Investment Offices
• Sub-Industry: Trading
• Current Symbol: NASDAQ:DMAAU
• CIK: 2028614
• Web: N/A
• Phone: (954) 870-3104
• Fax: N/A
• Employees: 2
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: N/A
• Beta: N/A